Berkeley Capital Partners LLC cut its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 76.9% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 537 shares of the medical equipment provider’s stock after selling 1,788 shares during the quarter. Berkeley Capital Partners LLC’s holdings in Intuitive Surgical were worth $256,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently modified their holdings of the company. Adviser Investments LLC purchased a new stake in Intuitive Surgical in the 2nd quarter worth approximately $115,000. McKinley Carter Wealth Services Inc. purchased a new stake in Intuitive Surgical in the 1st quarter worth approximately $132,000. Kaizen Advisory LLC lifted its holdings in Intuitive Surgical by 156.0% in the 2nd quarter. Kaizen Advisory LLC now owns 279 shares of the medical equipment provider’s stock worth $133,000 after buying an additional 170 shares during the period. Psagot Investment House Ltd. purchased a new stake in Intuitive Surgical in the 2nd quarter worth approximately $133,000. Finally, Rockefeller Capital Management L.P. purchased a new stake in Intuitive Surgical in the 2nd quarter worth approximately $142,000. Institutional investors own 85.09% of the company’s stock.

In other news, insider Craig H. Barratt sold 2,500 shares of the stock in a transaction that occurred on Monday, June 4th. The stock was sold at an average price of $482.00, for a total value of $1,205,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, COO Salvatore Brogna sold 2,655 shares of the stock in a transaction that occurred on Friday, June 1st. The stock was sold at an average price of $463.15, for a total value of $1,229,663.25. Following the completion of the transaction, the chief operating officer now directly owns 2,050 shares of the company’s stock, valued at approximately $949,457.50. The disclosure for this sale can be found here. Insiders sold a total of 118,026 shares of company stock valued at $60,907,375 in the last three months. Corporate insiders own 2.20% of the company’s stock.

Shares of NASDAQ:ISRG opened at $520.36 on Tuesday. Intuitive Surgical, Inc. has a 52-week low of $317.00 and a 52-week high of $539.30. The company has a market capitalization of $59.26 billion, a PE ratio of 72.37, a PEG ratio of 3.81 and a beta of 0.83.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, July 19th. The medical equipment provider reported $2.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.02 by $0.74. Intuitive Surgical had a return on equity of 20.56% and a net margin of 23.20%. The firm had revenue of $909.30 million during the quarter, compared to analyst estimates of $877.43 million. During the same quarter in the prior year, the company earned $5.95 EPS. The business’s revenue was up 19.8% compared to the same quarter last year. research analysts expect that Intuitive Surgical, Inc. will post 9.31 earnings per share for the current fiscal year.

Several equities research analysts have weighed in on ISRG shares. Piper Jaffray Companies increased their price objective on Intuitive Surgical to $460.00 and gave the stock a “neutral” rating in a report on Wednesday, April 18th. Cantor Fitzgerald increased their price objective on Intuitive Surgical to $510.00 and gave the stock an “overweight” rating in a report on Wednesday, April 18th. Leerink Swann reiterated an “outperform” rating and issued a $510.00 price objective (up previously from $475.00) on shares of Intuitive Surgical in a report on Wednesday, April 18th. Stifel Nicolaus increased their price objective on Intuitive Surgical from $480.00 to $515.00 and gave the stock a “buy” rating in a report on Wednesday, April 18th. Finally, Morgan Stanley increased their price objective on Intuitive Surgical from $500.00 to $525.00 and gave the stock an “overweight” rating in a report on Wednesday, April 18th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $513.69.

Intuitive Surgical Profile

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Recommended Story: Market Capitalization and Individual Investors

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.